Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 4
2007 2
2008 2
2010 2
2011 5
2012 6
2013 8
2014 4
2015 6
2016 1
2017 7
2018 7
2019 11
2020 13
2021 9
2022 10
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Global epidemiology of dyslipidaemias.
Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Pirillo A, et al. Nat Rev Cardiol. 2021 Oct;18(10):689-700. doi: 10.1038/s41569-021-00541-4. Epub 2021 Apr 8. Nat Rev Cardiol. 2021. PMID: 33833450 Review.
LOX-1, OxLDL, and atherosclerosis.
Pirillo A, Norata GD, Catapano AL. Pirillo A, et al. Mediators Inflamm. 2013;2013:152786. doi: 10.1155/2013/152786. Epub 2013 Jul 10. Mediators Inflamm. 2013. PMID: 23935243 Free PMC article. Review.
LDL-Cholesterol-Lowering Therapy.
Pirillo A, Norata GD, Catapano AL. Pirillo A, et al. 2020 Apr 30. In: von Eckardstein A, Binder CJ, editors. Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets [Internet]. Cham (CH): Springer; 2022. 2020 Apr 30. In: von Eckardstein A, Binder CJ, editors. Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets [Internet]. Cham (CH): Springer; 2022. PMID: 36122124 Free Books & Documents. Review.
LDL-Cholesterol-Lowering Therapy.
Pirillo A, Norata GD, Catapano AL. Pirillo A, et al. Handb Exp Pharmacol. 2022;270:73-101. doi: 10.1007/164_2020_361. Handb Exp Pharmacol. 2022. PMID: 32350699
Remnant cholesterol: A reliable prognostic marker?
Pirillo A, Catapano AL. Pirillo A, et al. Eur J Prev Cardiol. 2023 Apr 11:zwad107. doi: 10.1093/eurjpc/zwad107. Online ahead of print. Eur J Prev Cardiol. 2023. PMID: 37037665 No abstract available.
Biological Consequences of Dysfunctional HDL.
Pirillo A, Catapano AL, Norata GD. Pirillo A, et al. Curr Med Chem. 2019;26(9):1644-1664. doi: 10.2174/0929867325666180530110543. Curr Med Chem. 2019. PMID: 29848265 Free article. Review.
New Pharmacological Approaches to Target PCSK9.
Catapano AL, Pirillo A, Norata GD. Catapano AL, et al. Among authors: pirillo a. Curr Atheroscler Rep. 2020 Jun 3;22(7):24. doi: 10.1007/s11883-020-00847-7. Curr Atheroscler Rep. 2020. PMID: 32495301 Review.
102 results